Nanosonics
(ASX:NAN) and GE Healthcare have extended their relationship for the purification of ultrasound probes.
The disinfection company inked a three-year reseller agreement with GE Healthcare Distribution.
Nanosonics says the increase in sales and profit for its Northern American business will bolster shareholder value and help advance the trophon technology as the global standard of care.
The agreement will into effect on 1 July 2019.
Shares in Nanosonics
(ASX:NAN) are trading 1.83 per cent higher to $2.23.
